Pathologic response and long term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladder.

Abstract

Patients with tumor extending through the bladder wall with invasion of adjacent structures or lymph node metastases are seldom cured by radical surgery. Preoperative chemotherapy was given to 17 patients with T3-T4, N0, N+ tumor to assess operability and long-term survival. Tumor downstaging (T0, Ta, T1, CIS, N0) occurred in 4 (80%) of the 5 T3 patients, and in 3 (25%) of the 12 patients with T4 tumors. All patients have been followed until death or for a minimum of 42 months (mean: 56 months, range 42 to 78 months). Surgery was possible in all patients. Long-term survival is realized in only 30%, suggesting that this approach did not alter the ultimate course of the natural history of the disease. Although local recurrence did not occur, 70% of the patients with downstaged cancers developed distant metastases.

• Authors: A S Abi-Aad, A Stenzl, R Figlin, J B deKernion
• Journal: Acta urologica Belgica (Acta Urol Belg) Vol. 61 Issue 4 Pg. 13-6 (Dec 1993) ISSN: 0001-7183 [Print] Belgium
• PMID: 8296684 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Vinblastine
• Doxorubicin
• Cisplatin
• Methotrexate

Topics

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Carcinoma in Situ (pathology)
• Carcinoma, Transitional Cell (drug therapy, pathology, surgery)
• Cisplatin (administration & dosage)
• Doxorubicin (administration & dosage)
• Drug Administration Schedule
• Female
• Humans
• Male
• Methotrexate (administration & dosage)
• Middle Aged
• Neoplasm Staging
• Retrospective Studies
• Urinary Bladder Neoplasms (drug therapy, pathology, surgery)
• Vinblastine (administration & dosage)